@the_great_she_elephant wrote:
Domino wrote: One of the world's largest studies - the Recovery trial run by Oxford University - has involved 11,000 patients with coronavirus in hospitals across the UK and included testing hydroxychloroquine's effectiveness against the disease, along with other potential treatments.
It concluded that "there is no beneficial effect of hydroxychloroquine in patients hospitalised with Covid-19" and the drug has now been pulled from the trial.
4channel wrote: Well, that should make a few people happy.
In what possibe universe would news that a hoped for treatment had proved ineffective make anyone happy.
At the very least I am sure you would know that I was referring to people other than ordinary folk.
* One group of people that would be happy about the presented outcome of this so-called test done at Oxford would be those looking to profit on another kind of treatment.
* Others happy might be be those who want to win a debate or counter what someone else who has referenced the effectiveness of early stage Hydrox treatment.
* And there's those in politiics who would want to feel vindicated.
At the end of the day if something is known to be effective at an early stage then it should be better looked at by the people who are supposedly looking out for us. One of the worst things or possibly the worst thing that has tainted the hydroxychlorquine is becaause that buffoon Trump endorsed it early on. What better person than him to discredit something by association. Under proper medical supervision which is the way to be treated, it has worked. People won't be looking at this because of that buffoon.
THE WALL STREET JOURNAL
Hydroxychloroquine Given Early Helped Coronavirus Patients, Study Finds Analysis suggests certain Covid-19 patients could benefit from taking antimalaria drug early in their illness, though further research is needed
By Jared S. Hopkins
July 2, 2020 6:41 pm ET
An antimalarial drug helped reduce deaths in hospitalized patients infected with Covid-19, according to a large retrospective study published Thursday.
Coronavirus patients treated with the drug hydroxychloroquine within the first two days of admission were more likely to survive than patients who received other treatment, according to the study, which was published online by the International Journal of Infectious Diseases
https://www.wsj.com/articles/hydroxychloroquine-given-early-helped-coronavirus-patients-study-finds-...
==========================================================
Yale School of Public Health
Using Hydroxychloroquine and Other Drugs to Fight Pandemic
Professor Harvey Risch, M.D., Ph.D., is a researcher at the Yale School of Public Health with a specialty in cancer etiology, prevention and early diagnosis, and epidemiologic methods.
Like any treatment, prroper medical supervsion is the only way to go. If people want to be vaccinated then I respect their choice. with a better than 99% chance of survival without vaccine, an improvment with early stage treatmment is important.
